<DOC>
	<DOCNO>NCT00543426</DOCNO>
	<brief_summary>The primary purpose trial adopt Fuzheng Huayu tablets posthepatitic cirrhosis , build standard evaluation system efficacy traditional Chinese medicine ( TCM ) . The second purpose accord international clinical guideline specialty TCM build standard clinical trial regulation traditional Chinese medicine .</brief_summary>
	<brief_title>Fuzheng Huayu Tablets Against Posthepatitic Cirrhosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Clinical diagnosis B Post hepatitic cirrhosis . Male female patient 18~65 year old . Written informed consent . ChildPugh C 12 , ALT &gt; 2×ULN , TBiL &gt; 2×ULN , combine hepatic encephacopathy , Obstinate ascites , bleed tendency , hepatorenal syndrome , primary liver cancer . Combined severe heart , gallbladder , kidney , endocrine system , hemopoietic system nervous system disease . Deformed man law . Pregnancy breast feeding woman , unwilling contraception . Irritability body constitution , irritability Fuzheng Huayu Capsules . Enter trial lately one month . Other cause cirrhosis .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Fuzheng Huayu Tablets</keyword>
	<keyword>Multicenter clinical study</keyword>
</DOC>